Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
Objective: The rates of obesity and cigarette smoking are much higher in patients with schizophrenia compared to the general population. This study was to examine whether naltrexone and bupropion combination treatment can help weight loss and smoking cessation in patients with schizophrenia.Methods:...
Main Authors: | Xuechan Lyu, Jiang Du, Guilai Zhan, Yujie Wu, Hang Su, Youwei Zhu, Fredrik Jarskog, Min Zhao, Xiaoduo Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00181/full |
Similar Items
-
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
by: Tek C
Published: (2016-05-01) -
Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures
by: Angeliki Siamidi, et al.
Published: (2021-04-01) -
Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats
by: Monica Alhadas Scudeler, et al.
Published: (2022-05-01) -
A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
by: Ali Ramazan Benli, et al.
Published: (2017-02-01) -
The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy
by: Carel W. le Roux, et al.
Published: (2022-07-01)